New results from the BLASST-1 trial show increases in downstaging and relapse-free survival
The multidisciplinary research team reported their findings in JAMA
Physicians explain findings from a recent study
The process could improve access for patients with end-stage kidney disease
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Important takeaways from a rare complication
American Urological Association guidelines and clinical expertise help set the stage
Study reviews institutional experience
The data behind new therapeutic agents and what’s next for improving patient care
A closer look at the updated guidance
Urologic oncology and female urology collaborate on prospective clinical trial
Advertisement
Advertisement